Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Neurodegeneration
Published in: Molecular Neurodegeneration 1/2015

Open Access 01-12-2015 | Research article

Synaptotagmins interact with APP and promote Aβ generation

Authors: Vivek Gautam, Carla D’Avanzo, Oksana Berezovska, Rudolph E. Tanzi, Dora M. Kovacs

Published in: Molecular Neurodegeneration | Issue 1/2015

Login to get access

Abstract

Background

Accumulation of the β-amyloid peptide (Aβ) is a major pathological hallmark of Alzheimer’s disease (AD). Recent studies have shown that synaptic Aβ toxicity may directly impair synaptic function. However, proteins regulating Aβ generation at the synapse have not been characterized. Here, we sought to identify synaptic proteins that interact with the extracellular domain of APP and regulate Aβ generation.

Results

Affinity purification-coupled mass spectrometry identified members of the Synaptotagmin (Syt) family as novel interacting proteins with the APP ectodomain in mouse brains. Syt-1, −2 and −9 interacted with APP in cells and in mouse brains in vivo. Using a GST pull-down approach, we have further demonstrated that the Syt interaction site lies in the 108 amino acids linker region between the E1 and KPI domains of APP. Stable overexpression of Syt-1 or Syt-9 with APP in CHO and rat pheochromocytoma cells (PC12) significantly increased APP-CTF and sAPP levels, with a 2 to 3 fold increase in secreted Aβ levels in PC12 cells. Moreover, using a stable knockdown approach to reduce the expression of endogenous Syt-1 in PC12 cells, we have observed a ~ 50 % reduction in secreted Aβ generation. APP processing also decreased in these cells, shown by lower CTF levels. Lentiviral-mediated knock down of endogenous Syt-1 in mouse primary neurons also led to a significant reduction in both Aβ40 and Aβ42 generation. As secreted sAPPβ levels were significantly reduced in PC12 cells lacking Syt-1 expression, our results suggest that Syt-1 regulates Aβ generation by modulating BACE1-mediated cleavage of APP.

Conclusion

Altogether, our data identify the synaptic vesicle proteins Syt-1 and 9 as novel APP-interacting proteins that promote Aβ generation and thus may play an important role in the pathogenesis of AD.
Appendix
Available only for authorised users
Literature
1.
2.
Glenner GG, Wong CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120(3):885–90.PubMedCrossRef
3.
Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986;261(13):6084–9.PubMed
4.
Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A. 1986;83(11):4044–8.PubMedCentralPubMedCrossRef
5.
Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120(4):545–55.PubMedCrossRef
6.
Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron. 2004;44(1):181–93.PubMedCrossRef
7.
8.
Kojro E, Fahrenholz F. The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell Biochem. 2005;38:105–27.PubMedCrossRef
9.
Citron M. Beta-secretase inhibition for the treatment of Alzheimer’s disease--promise and challenge. Trends Pharmacol Sci. 2004;25(2):92–7.PubMedCrossRef
10.
De Strooper B. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron. 2003;38(1):9–12.PubMedCrossRef
11.
De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998;391(6665):387–90.PubMedCrossRef
12.
Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 1992;357(6378):500–3.PubMedCrossRef
13.
Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402(6761):537–40.PubMedCrossRef
14.
Vassar R. BACE1: the beta-secretase enzyme in Alzheimer’s disease. J Mol Neurosci. 2004;23(1–2):105–14.PubMedCrossRef
15.
Xia W, Wolfe MS. Intramembrane proteolysis by presenilin and presenilin-like proteases. J Cell Sci. 2003;116(Pt 14):2839–44.PubMedCrossRef
16.
Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–12.PubMedCrossRef
17.
Spires TL, Hyman BT. Neuronal structure is altered by amyloid plaques. Rev Neurosci. 2004;15(4):267–78.PubMedCrossRef
18.
Wang Z, Wang B, Yang L, Guo Q, Aithmitti N, Songyang Z, et al. Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci. 2009;29(35):10788–801.PubMedCentralPubMedCrossRef
19.
Ramaker JM, Swanson TL, Copenhaver PF. Amyloid precursor proteins interact with the heterotrimeric G protein Go in the control of neuronal migration. J Neurosci. 2013;33(24):10165–81.PubMedCentralPubMedCrossRef
20.
Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O’Dowd G, et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience. 1999;90(1):1–13.PubMedCrossRef
21.
Weyer SW, Klevanski M, Delekate A, Voikar V, Aydin D, Hick M, et al. APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J. 2011;30(11):2266–80.PubMedCentralPubMedCrossRef
22.
Buggia-Prevot V, Fernandez CG, Udayar V, Vetrivel KS, Elie A, Roseman J, et al. A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer’s disease Abeta production. Cell Rep. 2013;5(6):1552–63.PubMedCentralPubMedCrossRef
23.
Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron. 2000;28(2):449–59.PubMedCrossRef
24.
Buxbaum JD, Thinakaran G, Koliatsos V, O’Callahan J, Slunt HH, Price DL, et al. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci. 1998;18(23):9629–37.PubMed
25.
Lazarov O, Lee M, Peterson DA, Sisodia SS. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci. 2002;22(22):9785–93.PubMed
26.
Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron. 2003;37(6):925–37.PubMedCrossRef
27.
Sheng JG, Price DL, Koliatsos VE. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis. J Neurosci. 2002;22(22):9794–9.PubMed
28.
Bai Y, Markham K, Chen F, Weerasekera R, Watts J, Horne P, et al. The in vivo brain interactome of the amyloid precursor protein. Mol Cell Proteomics. 2008;7(1):15–34.PubMedCrossRef
29.
Norstrom EM, Zhang C, Tanzi R, Sisodia SS. Identification of NEEP21 as a ss-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro. J Neurosci. 2010;30(46):15677–85.PubMedCentralPubMedCrossRef
30.
Chapman ER. How does synaptotagmin trigger neurotransmitter release? Annu Rev Biochem. 2008;77:615–41.PubMedCrossRef
31.
Craxton M. Evolutionary genomics of plant genes encoding N-terminal-TM-C2 domain proteins and the similar FAM62 genes and synaptotagmin genes of metazoans. BMC Genomics. 2007;8:259.PubMedCentralPubMedCrossRef
32.
Perin MS, Brose N, Jahn R, Sudhof TC. Domain structure of synaptotagmin (p65). J Biol Chem. 1991;266(1):623–9.PubMed
33.
Perin MS, Fried VA, Mignery GA, Jahn R, Sudhof TC. Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature. 1990;345(6272):260–3.PubMedCrossRef
34.
Xu J, Mashimo T, Sudhof TC. Synaptotagmin-1, −2, and −9: Ca(2+) sensors for fast release that specify distinct presynaptic properties in subsets of neurons. Neuron. 2007;54(4):567–81.PubMedCrossRef
35.
Frykman S, Hur JY, Franberg J, Aoki M, Winblad B, Nahalkova J, et al. Synaptic and endosomal localization of active gamma-secretase in rat brain. PLoS One. 2010;5(1), e8948.PubMedCentralPubMedCrossRef
36.
Groemer TW, Thiel CS, Holt M, Riedel D, Hua Y, Huve J, et al. Amyloid precursor protein is trafficked and secreted via synaptic vesicles. PLoS One. 2011;6(4), e18754.PubMedCentralPubMedCrossRef
37.
38.
Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT. Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D. Neuropharmacology. 2013;74:96–107.PubMedCrossRef
39.
Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996;68(5):850–8.PubMedCrossRef
40.
Williamson TG, Mok SS, Henry A, Cappai R, Lander AD, Nurcombe V, et al. Secreted glypican binds to the amyloid precursor protein of Alzheimer’s disease (APP) and inhibits APP-induced neurite outgrowth. J Biol Chem. 1996;271(49):31215–21.PubMedCrossRef
41.
Ho A, Sudhof TC. Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Natl Acad Sci U S A. 2004;101(8):2548–53.PubMedCentralPubMedCrossRef
42.
Osterfield M, Egelund R, Young LM, Flanagan JG. Interaction of amyloid precursor protein with contactins and NgCAM in the retinotectal system. Development. 2008;135(6):1189–99.PubMedCrossRef
43.
Zhou X, Hu X, He W, Tang X, Shi Q, Zhang Z, et al. Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition. FASEB J. 2011;25(9):3146–56.PubMedCentralPubMedCrossRef
44.
Shin OH, Rizo J, Sudhof TC. Synaptotagmin function in dense core vesicle exocytosis studied in cracked PC12 cells. Nat Neurosci. 2002;5(7):649–56.PubMed
45.
Wang CT, Grishanin R, Earles CA, Chang PY, Martin TF, Chapman ER, et al. Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles. Science. 2001;294(5544):1111–5.PubMedCrossRef
46.
Moore JM, Papke JB, Cahill AL, Harkins AB. Stable gene silencing of synaptotagmin I in rat PC12 cells inhibits Ca2 + −evoked release of catecholamine. Am J Physiol Cell Physiol. 2006;291(2):C270–81.PubMedCrossRef
47.
Roden WH, Papke JB, Moore JM, Cahill AL, Macarthur H, Harkins AB. Stable RNA interference of synaptotagmin I in PC12 cells results in differential regulation of transmitter release. Am J Physiol Cell Physiol. 2007;293(6):C1742–52.PubMedCrossRef
48.
Dawkins E, Small DH. Insights into the physiological function of the beta-amyloid precursor protein: beyond Alzheimer’s disease. J Neurochem. 2014;129(5):756–69.PubMedCentralPubMedCrossRef
49.
De Strooper B, Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci. 2000;113(Pt 11):1857–70.PubMed
50.
51.
Perreau VM, Orchard S, Adlard PA, Bellingham SA, Cappai R, Ciccotosto GD, et al. A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer’s disease. Proteomics. 2010;10(12):2377–95.PubMedCrossRef
52.
Ma QH, Futagawa T, Yang WL, Jiang XD, Zeng L, Takeda Y, et al. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nat Cell Biol. 2008;10(3):283–94.PubMedCrossRef
53.
Park JH, Gimbel DA, GrandPre T, Lee JK, Kim JE, Li W, et al. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci. 2006;26(5):1386–95.PubMedCentralPubMedCrossRef
54.
Kohli BM, Pflieger D, Mueller LN, Carbonetti G, Aebersold R, Nitsch RM, et al. Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J Proteome Res. 2012;11(8):4075–90.PubMedCrossRef
55.
Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445(7124):168–76.PubMedCrossRef
56.
Mittelsteadt T, Seifert G, Alvarez-Baron E, Steinhauser C, Becker AJ, Schoch S. Differential mRNA expression patterns of the synaptotagmin gene family in the rodent brain. J Comp Neurol. 2009;512(4):514–28.PubMedCrossRef
57.
Dean C, Dunning FM, Liu H, Bomba-Warczak E, Martens H, Bharat V, et al. Axonal and dendritic synaptotagmin isoforms revealed by a pHluorin-syt functional screen. Mol Biol Cell. 2012;23(9):1715–27.PubMedCentralPubMedCrossRef
58.
Yao J, Kwon SE, Gaffaney JD, Dunning FM, Chapman ER. Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles. Nat Neurosci. 2012;15(2):243–9.CrossRef
59.
Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 2008;58(1):42–51.PubMedCentralPubMedCrossRef
60.
Nordstedt C, Caporaso GL, Thyberg J, Gandy SE, Greengard P. Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem. 1993;268(1):608–12.PubMed
61.
Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci. 2005;25(5):1219–25.PubMedCrossRef
62.
Yang G, Gong YD, Gong K, Jiang WL, Kwon E, Wang P, et al. Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci Lett. 2005;384(1–2):66–71.PubMedCrossRef
63.
Lee HW, Park JW, Sandagsuren EU, Kim KB, Yoo JJ, Chung SH. Overexpression of APP stimulates basal and constitutive exocytosis in PC12 cells. Neurosci Lett. 2008;436(2):245–9.PubMedCrossRef
64.
Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, Zhang D, et al. Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J Neurosci. 2005;25(29):6755–64.PubMedCrossRef
65.
Del Prete D, Lombino F, Liu X, D’Adamio L. APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate pre-synaptic vesicles functions. PLoS One. 2014;9(9), e108576.PubMedCentralPubMedCrossRef
66.
Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R. The Alzheimer’s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol. 2013;126(3):329–52.PubMedCentralPubMedCrossRef
67.
Miesenbock G, De Angelis DA, Rothman JE. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature. 1998;394(6689):192–5.PubMedCrossRef
68.
Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735–41.PubMedCrossRef
Metadata
Title
Synaptotagmins interact with APP and promote Aβ generation
Authors
Vivek Gautam
Carla D’Avanzo
Oksana Berezovska
Rudolph E. Tanzi
Dora M. Kovacs
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2015
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/s13024-015-0028-5

Other articles of this Issue 1/2015

Molecular Neurodegeneration 1/2015 Go to the issue

Research article

Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample

Research article

Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator

Research article

Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain

Review

Genetics ignite focus on microglial inflammation in Alzheimer’s disease

Research article

The topology of pen-2, a γ-secretase subunit, revisited: evidence for a reentrant loop and a single pass transmembrane domain

Research article

Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS